Clinical trial
Evaluation of the Effects of MC-1 Alone and in Combination With an ACE Inhibitor on Ambulatory Blood Pressure and Metabolic Function in Hypertensive Patients With Type 2 Diabetes Mellitus
NCT00157729 is registered in ClinicalTrials.gov with Medicure as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Effects of MC-1 Alone and in Combination With an ACE Inhibitor on Ambulatory Blood Pressure and Metabolic Function in Hypertensive Patients With Type 2 Diabetes Mellitus
- Lead sponsor
- Medicure
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2004
- Completion date
- July 31, 2005
- Enrollment
- 160
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus type 2, hypertension, metabolic syndrome